Trial Details

COMPLETED
Basic Information
Clinical ID c3833
Identifier NCT01466374
Trial Title Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: Placebo|DRUG: Placebo|DRUG: BMS-936557 (Anti-IP-10 Antibody)|DRUG: BMS-936557 (Anti-IP-10 Antibody)|DRUG: BMS-936557 (Anti-IP-10 Antibody)|DRUG: BMS-936557 (Anti-IP-10 Antibody)|DRUG: BMS-936557 (Anti-IP-10 Antibody)
Participant Information
Sponsor Bristol-Myers Squibb
City Santa Monica
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2011-12
Primary Completion Date 2014-06
Completion Date 2014-12